OTHER EVENTS
On January 18, 2008, the Registrant entered into a nonbinding letter of intent with Nanobac Pharmaceuticals, Incorporated (Nanobac). This letter of intent was amended on February 1, 2008. This letter of intent and amendment are filed with this 8-K.
ITEM 9.01
EXHIBITS
99.01 Non-binding letter of intent dated January 18, 2008 between Nanobac Pharmaceuticals, Incorporated and the Registrant.
99.02 Amendment dated February 1, 2008 to the non-binding letter of intent between Nanobac Pharmaceuticals, Incorporate and the Registrant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
| DNAPrint Genomics, Inc. | |
|
|
|
| |
|
|
|
|
|
|
| By: | /s/ Richard Gabriel |
|
|
|
| Richard Gabriel |
|
|
|
| Chief Executive Officer & President | |